167758-88-5

Basic information

• Product Name: ethyl 4-fluoro-2-methylbenzoate
• Synonyms: ethyl 4-fluoro-2-methylbenzoate;4-Fluoro-2-methylbenzoic acid ethyl ester
• CAS NO: 167758-88-5
• Molecular Formula: C₁₀H₁₁FO₂
• Molecular Weight: 182.1915432
• Mol File: 167758-88-5.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 226.2°C at 760 mmHg
• Flash Point: 88.2°C
• Appearance: /
• Density: 1.108g/cm³
• Vapor Pressure: 0.0828mmHg at 25°C
• Refractive Index: 1.489
• CAS DataBase Reference: ethyl 4-fluoro-2-methylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4-fluoro-2-methylbenzoate(167758-88-5)
• EPA Substance Registry System: ethyl 4-fluoro-2-methylbenzoate(167758-88-5)

Safety Data

• Hazardous Substances Data: 167758-88-5(Hazardous Substances Data)

Usage

General Description

Ethyl 4-fluoro-2-methylbenzoate is a chemical compound with the molecular formula C10H11FO2. It is commonly used as a flavor and fragrance ingredient in the food and cosmetic industries. ethyl 4-fluoro-2-methylbenzoate is a colorless to light yellow liquid with a fruity odor and is often found in fruit-flavored products. Ethyl 4-fluoro-2-methylbenzoate is also used in the synthesis of pharmaceuticals and agrochemicals due to its unique aromatic properties. Additionally, it is considered to be a potentially hazardous chemical and should be handled with care and proper safety precautions.

InChI:InChI=1/C10H11FO2/c1-3-13-10(12)9-5-4-8(11)6-7(9)2/h4-6H,3H2,1-2H3

Upstream product

• 452-63-1 2-Bromo-5-fluorotoluene 
• 541-41-3 chloroformic acid ethyl ester 
• 321-21-1 4-fluoro-2-methylbenzoic acid 
• 75-03-6 ethyl iodide 
• 64-17-5 ethanol 

Downstream Products

• 1358575-02-6 4-(3-(3-fluoro-5-(trifluoromethyl)benzyl)-5-methyl-1H-1,2,4-triazol-1-yl)-2-methylbenzamide 

Relevant articles and documents

Pyridazone derivative and its uses

The present invention belongs to the pharmaceutical field, specifically relates to a pyridazone derivative and its uses, compounds thereof and pharmaceutically acceptable salts, solvates including hydrates, polycrystallines, prodrugs, co-crystallines, tau

INFLUENZA VIRUS REPLICATION INHIBITOR AND USES THEREOF

The invention belongs to the field of medicine, and particularly relates to a novel compound as a replication inhibitor of influenza virus and a preparation method thereof, a pharmaceutical composition comprising the compound and use of the compound and pharmaceutical composition thereof in treating influenza. The present invention provides a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, The compound of the present invention can inhibit influenza virus well, and/or has lower cytotoxicity, better in vivo pharmacokinetic properties and in vivo pharmacodynamic properties.

Novel cyclic amide derivatives

Novel compounds represented by the following formula (I) that act as a ligand to sigma receptor/binding cite and a medicament comprising the same as an active ingredient: wherein X represents an alkyl group, an aryl group, a heterocyclic group or the like; Q represents a group represented by —CH2—, —CO—, —O—, —CH(OR7)— or the like wherein R7 represents a hydrogen atom, an alkyl group or the like; n represents an integer of from 0 to 5; R1 and R2 each represent a hydrogen atom, an alkyl group or the like; B represents either of the following groups: wherein R3, R4, R5, and R6 each represent a hydrogen atom, a halogen atom, an alkoxyl group or the like; m represents 1 or 2; and the ring of: represents an aromatic heterocyclic ring.